Tag: Atossa Genetics

  • Why need to watch: AMAG Pharmaceuticals (NASDAQ:AMAG), Atossa Genetics (NASDAQ:ATOS), Oxford Immunotec Global PLC (NASDAQ:OXFD), JX HLDGS (OTCMKTS: JXHLY), Mitsubishi Estate (OTCMKTS:MITEY)

    On 11 JUNE AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced the appointment of Melissa Bradford Klug as senior vice president of business development and strategy. Ms. Klug brings a wealth of hands-on business development, licensing and strategic partnering experience, as well as extensive leadership skills to AMAG’s executive team. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) net profit margin is -15.30% and weekly performance is 4.95%. On last trading day company shares ended up $19.31. Analysts mean target price for the company is $23.33. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) distance from 50-day simple moving average (SMA50) is 6.80%.

    On 27 MAY Atossa Genetics Inc (NASDAQ:ATOS) announced that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference in New York City at the Grand Hyatt Hotel. Kyle Guse, CFO and General Counsel, will present the company’s business model and growth strategy. Atossa Genetics Inc (NASDAQ:ATOS) is also a featured presenter at the LD MICRO Invitational Conference, at the Luxe Sunset, Los Angeles, where Mr. Guse will present on Wednesday, June 4th, 2014 at 12:30pm PDT, Track 4. Atossa Genetics Inc (NASDAQ:ATOS) shares fell -3.13% in last trading session and ended the day on $1.55. ATOS Gross Margin is 40.00% and its return on assets is -77.90%. Atossa Genetics Inc (NASDAQ:ATOS) quarterly performance is -12.43%.

    On 2 JUNE Oxford Immunotec Global PLC (NASDAQ:OXFD) announced first quarter 2014 financial results. Revenue for the first quarter of 2014 was $12.3 million, representing 60% growth over the first quarter 2013 revenue of $7.7 million. United States revenue was $5.0 million in the first quarter of 2014 representing 56% growth over the same period’s revenue of $3.2 million in the prior year. Our growth continued to be driven by the acquisition of new customers as well as higher utilization by existing customers. Oxford Immunotec Global PLC (NASDAQ:OXFD) shares moved up 3.74% in last trading session and was closed at $17.49, while trading in range of $16.45 – $18.34. Oxford Immunotec Global PLC (NASDAQ:OXFD) year to date (YTD) performance is -9.75%.

    JX HLDGS INC ADR (OTCMKTS: JXHLY) ended the last trading day at $ 10.57.

    On 4 JUNE Mitsubishi Estate Co Ltd (ADR) (OTCMKTS:MITEY) presented the Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Mitsubishi Estate Co Ltd (ADR) (OTCMKTS: MITEY) since January 2007. These reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Mitsubishi Estate Co Ltd (ADR) (OTCMKTS:MITEY) on last trading day company shares ended up $24.48.